Updates in Therapeutics for Folliculitis Decalvans: A Systematic Review with Evidence-Based Analysis

    August 2018 in “ Journal of the American Academy of Dermatology ”
    Pooja H. Rambhia, Rosalynn R.Z. Conic, Aizuri Murad … Wilma F. Bergfeld
    Studysummary This study reported that a 10-week course of clindamycin and rifampicin was commonly used for treating folliculitis decalvans but the evidence on its efficacy remains inconclusive due to the low quality of available studies.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on jaad.org →
    Discuss this study in the Community →

    Research cited in this study 6

    1. Folliculitis Decalvans: Effectiveness of Therapies and Prognostic Factors in a Multicenter Series of 60 Patients with Long-Term Follow-Up Journal of The American Academy of Dermatology · 2018
    2. Isotretinoin Treatment for Folliculitis Decalvans: A Retrospective Case-Series Study International Journal of Dermatology · 2018
    3. Oral Isotretinoin as the Most Effective Treatment in Folliculitis Decalvans: A Retrospective Comparison of Different Treatment Regimens in 28 Patients Journal of the European Academy of Dermatology and Venereology · 2015
    4. Folliculitis Decalvans: A Multicenter Review of 82 Patients Journal of the European Academy of Dermatology and Venereology · 2015
    5. Retrospective Review of Folliculitis Decalvans in 23 Patients with Course and Treatment Analysis of Long-Standing Cases Journal of Cutaneous Medicine and Surgery · 2015
    6. Folliculitis Decalvans Including Tufted Folliculitis: Clinical, Histological, and Therapeutic Findings British Journal of Dermatology · 1999